LivaNova Reports Fourth Quarter and Full-Year 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Livanova (LIVN) PT Raised to $104 at Needham & Company
February 28, 2018 3:39 PM ESTNeedham & Company raised its price target on Livanova (NASDAQ: LIVN) to $104.00 (from $97.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "LIVN beat consensus revenue and EPS in 4Q17. Management provided 2018 revenue and adjusted EPS guidance that were both above consensus. Neuromodulation... More
